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Immunodominant Antigens of Actinobacillus actinomycetemcomitans in
Antibody Positive Subjects
AB STRACT
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This study was initiated to look for characteristics of the
irnmunodominant antigen(s) of Actinobacillus actinomycetemcomitans (Aa)
that might help explain the high antibody titers reactive with this organism in
periodontitis patients.

Radioimmunoassays (RIA) and limiting dilution

analysis on western blots were used to identify and characterize the
irnmunodominant antigens of Aa in high responder patients (Le. patients with
high antibody titers). Additional experiments focused on specific responding
subjects with a range of antibody titers to serotype b (AaY4). This group
included both white and black subjects. Similar studies then examined the
irnmunodominant antigens of Aa serotypes a and c.

The Aa serotype

specificity of the high responders was determined and further work was
confined to individuals responding specifically to serotypes a or c. The
results indicated that the irnmunodominant antigen of Aa Y4 in all high
responders was heat and papain stable. Limiting dilution analysis on western
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blots showed that a large diffuse band resembling carbohydrate was the
immunodominant antigen.

Partially purified AaY4 carbohydrate also

contained the large diffuse band. Double immunodiffusion (Ouchterlony)
tests indicated that the dominant antigen recognized in the carbohydrate
extract by the patients' sera was the same antigen recognized by serotype b
specific rabbit antiserum which has been previously shown to react with the
serotype specific carbohydrate of AaY4. When the subjects with specific
antibody responses covering a range of positive antibody titers were
examined, 95% of the subjects were responding to the smeared serotype
specific carbohydrate antigen on western blots.

For serotype-a, no

immunodominant antigen was common to the majority of high responding
subjects. For serotype-c two antigens were immunodominant in the majority
of the high responding patients: 92% had an antigen with a diffuse smeared
appearance on western blots typical of a carbohydrate antigen and 67% had
an approximately 1 5Kd antigen. The smeared antigen gave a reaction of
identity with patient serum and serotype c specific rabbit antiserum in
double immunodiffusion assays.

These findings indicated that the

immunodominant antigen for serotypes-b and-c in high responding subjects
was the serotype specific carbohydrate.

The same antigen was

immunodominant for subjects with a range of antibody titers to AaY4. The
dominant antigen was highly variable for serotype-a. These antigens were
highly immunogenic.

This immunogenicity may explain the enormous

antibody titers observed for Aa in response to what appears to be a small
quantity of antigen.

INTRODUCTION

Periodontal disease is characterized by loss of the supporting tissues of teeth.
It

has been shown that the tissue destruction associated with the disease only

occurs in the presence of bacterial plaque. As the disease progresses the
normal relationship of the gingiva, gingival connective tissue, and bone, with
the tooth is lost.

Normally, teeth are attached to supporting bone by

periodontal ligament fibers which extend from the cementum of the tooth
into the alveolar bone. The gingiva in a similar manner is attached to the
tooth by connective tissue fibers. In health they attach to a small amount of
root surface that is not within the alveolar bone. Therefore, the gingival
attachment extends coronally to the enamel (i.e. the cementoenamel
junction). Periodontal disease begins as the gingival fibers detach from the
root surface. This is followed by loss of alveolar bone and periodontal
ligament fibers. This attachment loss can become extreme resulting in tooth
loss. There are three major types of periodontal disease: adult periodontitis,
severe periodontitis (generalized juvenile periodontitis or rapidly
progressive periodontitis), and juvenile periodontitis (localized).

Adult

periodontitis is characterized by comparatively slow loss of attachment with
active and stable periods throughout a patient's life. Severe periodontitis is a
type of early onset periodontitis where all or many of the patient's teeth are
affected by rapid attachment loss. Individuals with this disease are clinically
identified by their young age and rapid rate of periodontal destruction.
Severe periodontitis has similar characteristics to juvenile periodontitis and,
1
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therefore, is sometimes referred to as generalized juvenile periodontitis.
Localized juvenile periodontitis is another form of early onset periodontitis
that usually begins during puberty. It has a localized pattern of disease
affecting first molars and incisors preferentially.

Additional teeth may

become affected as the individual becomes older. Older individuals that have
a generalized pattern of attachment loss where an earlier localized pattern of
disease can be documented are often classified as juvenile periodontitis
patients. The bony lesions in these subjects are typically deep vertical defects
with the adjacent tooth unaffected. Early onset forms of periodontal disease
have a familial tendency which suggests a genetic basis to these diseases. In
addition, juvenile periodontitis patients often have defects in neutrophil
chemotaxis. It is also interesting to note that a similar immune defect can be
found in juvenile diabetic patients with early onset periodontal disease (15).
There has been considerable debate concerning the specific and non
specific plaque hypothesis. The specific plaque hypothesis suggests one
organism is the primary etiologic agent for periodontal disease.

This

hypothesis would then support the idea that Koch's postulates could be
satisfied for periodontal disease. The non-specific plaque hypothesis suggests
that periodontal disease is a function of increased bacterial load with the same
species in the same relative amounts as found in health. While this issue is
still a matter of debate, it appears that the non-specific plaque hypothesis does
not describe the flora found in diseased individuals. Periodontal patients not
only have an increase in total numbers of bacteria, but the composition of the
flora is altered ( 19). There is a shift from a flora where gram positive cocci
predominate to one where gram negative anaerobic bacilli predominate. It
may be that this general shift to gram negative organisms results in disease.
In this

case a mixed infection of predominantly gram negative anaerobic rods
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would result in disease in susceptible individuals. It still remains a possibility
that one or only a few specific organisms are responsible for disease. Three
to four hundred organisms have been identified in sites affected with
periodontal disease.

Many of these organisms are difficult to culture.

Utilizing the most effective techniques available, it is still not possible to
culture all of the organisms present in the periodontal lesion. An important
pathogen may be missed (possible example: the "large Treponeme") (1 9).
Some of the four hundred bacterial species have strong association with
periodontal disease even though they have yet to satisfy Koch's postulates.
Actinobacillus actinomycetemcomitans

(Aa), a gram negative organism

frequently isolated from lesions of juvenile periodontitis ( 1 , 1 3 , 1 9,30), is
thought to be a major etiologic agent of this form of periodontal disease (21).
There has been some disagreement on the degree of association with disease
and the proportion of the flora in diseased sites. Some investigators have
indicated that this organism is found in large numbers in almost all juvenile
periodontitis lesions (32,1). Others have found the organism associated with
diseased sites less frequently and in a smaller proportion of the flora ( 1 9).
Actinobacillus actinomycetemcomitans

(AaY4) has been shown to elicit

remarkably high antibody titers in juvenile periodontitis (4, 16,18,20,25,26).
This antibody response has been shown to be protective in patients with early
onset periodontits (6). Individuals that find the organism frequently in high
numbers cite this data as evidence that the organism is indeed highly
prevalent among juvenile periodontitis patients. They suggest that the high
antibody titers are the result of large numbers of Aa organisms being present
in the periodontal pocket (30,32). However, other periodontitis associated
organisms such as Fusobacterium nucleatum elicit comparatively lower titers
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(24,25) even though they represent a larger proportion of the flora for most
patients (19).

Rational For This Study

This study was initiated to examine the immunodominant antigens of
Actinobacillus

actinomycetemcomitans.

It was reasoned that the

immunodominant antigens of Aa might have unique characteristics that
might make them potent immunogens. This would explain the enormous
antibody titers reactive with this organism that have been observed.
Identifying the immunodominant antigens might also provide information
regarding a patient's prognosis as antibody to this organism has been shown
to be protective (6). The immunodominant antigens might also make good
candidates for vaccines that could elicit a protective response.
The results of this study showed that the immunodominant antigen for Aa
serotype-a was highly variable from patient to patient. In contrast, most
patients with high antibody titers to serotype-c responded to a 1 5Kd protein
antigen and/or a smeared antigen. The immunodominant antigen for Aa
serotype b (AaY4) in both high responders and specific responders over a
range of antibody titers was also a smeared antigen. This smeared antigen
recognized by patient serum was also recognized by serotype specific rabbit
antiserum.

These data support the conclusion that the smeared

immunodominant antigen was the serotype specific carbohydrate which
appears to be part of the Aa capsule (30,3 1 ,32). The carbohydrate antigens
therefore appear to be highly immunogenic and may be important antigens
for Aa serotypes-b and-c. This potent immunogenicity may explain the
enormous antibody titers that are found even when AaY4 is found in low
numbers.

MATERIALS AND METHODS

Human SUbjects

1 . Immunodominant Antigen for Actinobacillus actinomycetemcomitans
Strain Y4 in High Responder Patients
Subjects for these studies included 481 clinically characterized patients {227
black, 249 white, 3 Asian, 2 Indian (Asian) } at the Medical College of
V irginia/Virginia Commonwealth University Clinical Research Center for
Periodontal Diseases. These patients were diagnosed as follows: 76 juvenile
periodontitis, 72 severe periodontitis, 103 adult periodontitis, and 230 non
periodontitis.
2. Immunodominant Antigens of Actinobacillus actinomycetemcomitans
Serotype b in Early Onset Periodontitis Patients
Subj ects for these studies were selected from a group of 99 early
onset

peri o donti ti s

pati ents

at

the

Medi c al

C ol l e g e

of

Virgi ni a/Virgi ni a C ommonwealth U niversi ty C linical Research C enter
for Peri odontal Di seases .

The group of 99 subjects i ncluded 47

locali zed juveni le peri odonti ti s (IP) (39

Black, 9 whi te) and

52

generalized severe early onset peri odonti ti s ( SP) (28 bla ck , 24 whi te)
pati ents.

E leven AaY4 seroposi tive whi te, early onset peri odonti ti s

subjects wi th a range of antibody ti ters were selected for study ( see
Table 1 ) .

Black subj ects were then selected who had anti body ti ters

comparable to those found among the white subjects.
group i ncluded

18

black subj ects
5

and

11

Our study

white subj ects.

Thi s

6

included 2 1

individuals

with

severe

periodontitis

(SP)

and 8

individuals with juvenile periodontitis (JP).
3 . Immunodominant Antigens of Actinobacillus actinomycetemcomitans

Serotypes a and c in High responder Patients
Subjects for

these

studies included

1 50

clinically characterized

patients at the Medical College of Virginia/Virginia Commonwealth
University Clinical Research Center for Periodontal Diseases.
Specific criteria for each of these categories are the following:
(1) Juvenile periodontitis (JP): Subjects were 3 0 years of age or less with a

localized pattern of severe periodontal destruction limited to first molar or
incisor teeth and up to two additional teeth.
(2) Severe periodontitis (SP): Subjects were 3 5 years of age or less with a
generalized pattern of severe destruction with attachment loss of at least 5
mm

on 8 or more teeth, at least 3 of which were not first molars or incisors.

(3) Adult periodontitis (AP): Subjects were greater than 35 years of age

with chronic periodontitis generalized to all four quadrants of the mouth.
(4) Non-periodontitis (NP): Subjects of any age who had no evidence of

attachment loss, except recession on the buccal surface of anterior teeth, and
no more than one site or pockets no greater than 3mm .
Bacteria and Antigen preparation
Actinobacillus actinomycetemcomitans

serotypes a, b, and c (VPI strain

numbers: 14554 , 13 127, 14573 respectively) and Bacteroides gingivalis strain
D43B-4 were grown in mass culture by W.E.C. Moore and L.V.H. Moore of

Virginia Polytechnic Institute and State University. The bacterial strains
were centrifuged, frozen, shipped to the Medical College of V irginia,
Richmond, sonicated, and u sed to coat polystyrene RIA strips or run on
western blots. Protein concentrations in the sonicates were determined by

7

the method of Lowry et al (17). Tetanus toxoid, used as a control, was the
generous gift of Lederle, Inc.
Radioimmunoassay

Details of the solid-phase radioimmunoassay technique used for detection
and quantitation of specific antibody have been described (24). Briefly, 200
microliters of sonicated bacteria or TT (25- 100 micrograms per ml in
carbonate buffer, pH 9.6), was placed in each well of plastic assay strips
(Imrnulon 2; Dynatech Laboratories, Inc., Alexandria, Va.). The strips were
then incubated at 40C for 1 6 hours and then washed in tap water 20 times.
Sera were serially diluted (in the range of 1 :50 to 1 : 1 02,400) in diluent
(equal volumes of distilled water containing 10% nonfat dry milk and PBS,
pH 7.2). Each dilution of serum was added to two antigen coated wells and
two uncoated wells. The final quantity of serum in the well varied from
1 /250 m1 in the first well to 1/5 12,000 ml in the final well. The uncoated
wells served as a background control. After incubation and washing as
described above, 200 microliters of iodinated (specific activity, 25 uCi/ ug)
goat anti-human IgG (Fc specific) in diluent was added per well.

After

incubation and washing, radioactivity was measured to an accuracy of
1 O%(LKB instruments Inc., Rockville, Md; 1 282 Compugamma Counter).
The difference in counts (delta cpm between coated and uncoated wells) was
the basic data unit. A plot of delta cpm versus serum dilution was prepared.
A cut-off was selected (generally 3000- 10,000 delta cpm) that intersected the
curve at the end of the linear portion of the curve or point of inflection. This
was designated as the endpoint. The titer of the serum antibody was the
inverse of the dilution at the endpoint.
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Western Blot Analysis

Antigen preparations were diluted to the appropriate concentration for the
particular antigen (Aa 5ug/50ul, Bg 20ug/50ul, Tetanus toxoid 20ug/50ul) in
sample buffer (0.0626M Tris 10% glycerol 2.3% SDS pH 6.8) and boiled for
90 seconds.

The running buffer was 0.025M Tris containing 0.192M

Glycine and 0.1% SDS. 5-20% linear gradient polyacrylamide gels were run
at 30 milliamperes per gel until the smallest prestained molecular weight
marker (Bethesda Research Laboratories Life Technologies, Inc.
Gaithersburg, MD.) reached the bottom of the gel (approximately 5 hours).
A BIO-RAD SE600 vertical gel apparatus and a BIO-RAD power supply
model 500/200 were used. Following electrophoresis the antigens were then
blotted to nitrocellulose in a BIO-RAD transblot cell for 5 hours at 200
milliamperes. The blots were incubated in equal volumes of distilled water
containing 10% nonfat dry milk and PBS, pH 7.2 for 1 hour to block non
specific binding (11). The blots were then cut into individual lanes to allow
treatment of replicate lanes with different dilutions of serum (diluted in equal
volumes of distilled water containing 10% nonfat dry milk and PBS, pH 7.2).
Each lane was incubated in 4 ml of diluent containing 0.5 ml of serum at the
lowest dilution and 1/1024,000 ml serum at the highest dilution.

The

separate nitrocellulose lanes were then incubated with patient serum for 16
hours (1-3 hours in some experiments) followed by 4 ten minute washes with
TTBS (Tween-20 Tris Buffered Saline).

The 16 hour incubation was

necessary to improve sensitivity. The lanes were then exposed to a 1:1000
dilution of alkaline phosphatase labeled goat anti-human IgG (H & L)(KPI
laboratories Inc., Gaithersburg, MD.) for 4 hours. This was followed by 4
more washes with TTBS. The blots were developed with the BCIP/NBT (5bromo-4-chloro-3-indoyl phosphate/nitro blue tetrazolium) phosphatase
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substrate system.

Some of the SDS-page gels were also stained with

Coomassie brilliant blue (Bio-Rad, 220 Maple Ave. Rockville Centre, N. Y.
11571) or Silver stain (Bio-Rad silver stain kit, Bio-Rad, 220 Maple Ave.
Rockville Centre, N. Y. 11571) (the method used was that described in the
Bio-Rad Trans-Blot and Inunun-Blot instruction manuals included with the
Trans-Blot unit).
C ompetition Assay

To determine the specificity of the antibody response for each patient the
competition assay was developed. Four replicate nitrocellulose lanes (for
each serotype) were stained (as described above in the western blot
technique, except incubation with primary and secondary antibody was for
one hour each). The patient serum used was either untreated or incubated
overnight with serotype-a, -b, or-c antigen (see Fig. 1 for illustration). It is
important to note that a large quantity of antigen was required to completely
eliminate staining (i.e. completely eliminate reactivity from the serum) in
some patients. To completely absorb antibody molecules reactive with the
antigen, serum was incubated (diluted 1/250) overnight with 3000ug of
antigen followed by an overnight incubation with antigen coated petri dishes.
These petri dishes were coated with antigen in the same manner as microtiter
plates in the RIA (24).

The patients' sera were then centrifuged in a

rnicrofuge at 6000 X g for 10 minutes to remove any insoluble material.
Double Immunodiffusion

Double immunodiffusion precipitin reactions were performed in agar gels
(Ouchterlony test), using the slide micromethod (20). The well cutters were
selected to produce wells of 10ul capacity in the center and six
circumferencial wells. The center well received 40ul of AaY4 carbohydrate
extract added in l Oul increments. The peripheral well received SuI of a 1/2
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dilution of human serum or rabbit serotype specific antiserum. After the
precipitin pattern developed, the gels were washed to remove excess protein,
dried and stained at room temperature in a 0.5% solution of Coomassie blue
R-250 in 10% acetic acid, 25% isopropanol in water. The excess stain was
removed by washing the slides in a 10% acetic acid solution. The rabbit
serotype specific antisera were the kind gift of Dr. Joseph Zambon of
Buffalo, NY.
Immunoelectro p h oresis

Immunoelectrophoresis was conducted in a 1.0% agarose gel in 0.02M
TRIS-barbiturate, pH 8.6 using a Pharmacia Flat Bed Apparatus with cooling
plate following the method described in the unit's instruction manual.
(Pharmacia Inc., 800 Centennial Ave. Piscataway, N.J. 08854).

AaY4

sonicate ( l 0u1 sonicate containing 43ug/ml protein) or AaY4 carbohydrate
extract (lOul) were added to the wells and electrophoresed for 60 minutes at
l OV/cm while cooled to 1O-140C. The troughs were then filled with 100ul of
a 1:8 dilution (as per instruction manual) of human serum and incubated at
room temperature for 18 hours. The gel was then pressed, washed (in PBS
pH 7.4 for 18 hours followed by a 60 min. wash in deionized water), and
dried. The gel was then stained with Coomassie blue.
Papain Digestion

Proteolytic digestion was accomplished by adding 200ul of papain (Sigma)
solution per well (containing O. l mg /ml in O.IM Phosphate,with O.OOIM Cys
0.002 ETDA buffer pH 6.2) to antigen coated plates and incubated for 4
hours at 370C (25). The antigen was digested after coating of microtiter
plates as it was reasoned this would prevent competition for binding sites on
the plates by papain (also a protein). The plates were then washed 20 times in
tap water. For western blots, papain solution was prepared as above with 7.5

1 1

mg/mI papain and the appropriate antigen was added to a concentration of 1
mg/mI. This mixture was then incubated for 4 hours at 370C. Following the
incubation, the mixture was concentrated to 0.5 ml with a Centriprep
concentrator (Amicon Corp. Scientific Systems Division, Danvers. MA) and
then diluted to the same concentration used for undigested antigen.
Protease K

Digestion

Proteolytic digestion was accomplished by placing a nitrocellulose lane
that had electrophoretically separated Aa serotype-c antigens electroblotted
to it in sample buffer (0.026 M Tris, 10% glycerol, 2.35 sodium dodecyl
sulfate [SDS] [pH 6.8]) containing 50 ug/mI protease K for 4 hours at 370C.
Proteolytic digestion of serotype-c sonicate (7ug protein/ml in PBS) was
accomplished by adding protease K to a concentration of 200ug/m1 and
incubating overnight at 370C.
Heat Treatment

Antigen preparations (Aa, Bg, or TT) were placed in a boiling water bath
for 45 minutes. Various temperatures and times studied in preliminary
experiments indicated that boiling for 45 minutes was necessary to virtually
eliminate reactivity with tetanus toxoid and Bg controls.
Carbohydrate Purification

Carbohydrate was partially purified from Aa by extraction with phenol
and water followed by precipitation of the carbohydrate from the aqueous
phase with cold ethanol (9). One milliliter of AaY4 whole cells (7S.5mg/ml)
was pelleted in an Eppendorf Microfuge. The pellet was then resolubilized in
23ml of 0.05M Tris,O.OOl METDA, 50ug/mI lysozyme (pH 7.5), and
incubated for 15 minutes at 370C. SDS was then added to a concentration of
1.5% to gently lyse the cells. Forty six milliliters of phenol were added and
the mixture shaken for 15 minutes. The mixture was then centrifuged at
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5900 X .G for 10 minutes at 40C. The aqueous layer was removed and two
volumes of cold 95% ethanol was slowly added. The mixture was then
centrifuged at 5900 X g for 10 minutes at 40C. The precipitate was then
dissolved in 23rnl of 20mM phosphate buffer. Ribonuclease (40uglrnl) and
deoxyribonuclease (40ug/ml) were added and incubated for 1 hour at 370C.
The extracted carbohydrate was concentrated to 0.5 rnl with a Centriprep
concentrator (Amicon corp.-Scientific Systems Division, Danvers, MA) and
then diluted in sample buffer one sixth the original volume.

In some

experiments, low molecular weight material was removed by concentrating
the extracted carbohydrate with a Centriprep concentrator having a 30kd
molecular weight cut off.

This was accomplished with 3 cycles of

concentration and resuspension in 10 ml deionized water.

In some

experiments, lipopolysaccharide was removed from the carbohydrate extract
with a lipid A binding affinity column (Detoxi-Gel; Pierce, Inc. box 117
Rockford, lli. 61105). The column was equilibrated with 3 bed volumes of
PBS pH 7.5. Twenty microliters of carbohydrate extract was then added to
the column which represented microgram amounts of LPS. According to the
manufacturer, each column has a binding capacity of 2 milligrams of LPS.
Six bed volumes of PBS were then added. Six bed volumes of effluent were
collected and concentrated with a centriprep concetrator.
L P S Purification
Actinobacillus actinoinycetemcomitans

lipopolysaccharide (a kind gift of

Dr. Frank Nichols, Univ. of Connecticut School of Dental Medicine) was
purified by the method of Westphal (28). Analysis of the phenoVwater LPS
extract on Coomassie stained SDS-page gels revealed several protein bands.
This AaY4 LPS preparation was therefore further treated with papain as
described above to digest contaminating protein.

RESULTS

1. hnmunodominant Antigen for Actinobacillus

actinomycetemcomitans

Strain Y4 in High Responder Patients
In

order to identify subjects with high anti-AaY4 antibody titers, sera

from 481 patients were assayed. Thirty-two subjects with the highest anti
AaY4 antibody titers (i.e. above 128,000 RIA units/ml) were selected for
further analysis. This was less than 10% of the total group with 26 being
black, 4 white, and 2 Asian. All but 2 of these subjects had early onset forms
of periodontitis i.e., 17JP, 13SP, lAP, and 1NP.
To determine the nature of the immunodominant antigens of AaY4,
antigen preparations were first subjected to heat treatment or papain
digestion. Antibody titers to these altered antigens were then determined by
RIA. Representative plots of delta CPM versus reciprocal dilution for AaY4
as well as TT and Bg which served as controls are shown in Figure 1. For
tetanus toxoid (Fig. 1 panel A) the titer for untreated antigen was 16,000 RIA
units/ml. Boiling the antigen decreased the titer to 2000 RIA units/ml and
papain digestion reduced the titer to 750 RIA units/ml. Similarly for Bg
(Fig. 1 panel B), a titer of 16,000 RIA units/ml for untreated antigen was
decreased to 4,000 RIA units/ml by papain and less than 500 RIA units/ml for
boiling. In contrast, a titer of 256,000 RIA units/ml for Aa (Fig. 1 panel C)
was unaffected by papain and only modestly decreased by boiling for 45

13

14

FIG. 1. Typical RIA curves showing the effect of boiling C+), and papain
digestion C-) of antigen on antibody titers as compared to untreated antigen
CD). Panels a, b, and c, respectively illustrate the antigens IT, Bg, and AaY4.
The dotted line locates the cut-off for each curve. The cut-off marks the point
in the linear portion of the curve slightly before the inflection point in the
lower portion of the curve. The antibody titer is defined as the inverse of the
serum dilution at the end point.
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The mean antibody titers for all 32 patients' sera is summarized in

Figure 2. These results indicate that the antibody titer for IT (this control
was applied to 4 of the 32 subjects) was virtually eliminated by both papain
treatment and boiling. In contrast,

antibody titers against AaY4 were

unaffected by papain digestion and only modestly decreased by boiling.
To more directly examine individual antigens responsible for the antibody
responses, westem blots were prepared. As a control for the effectiveness of
enzyme digestion, Bg antigen was examined by westem blot analysis with and
without papain treatment. At low dilution of patient serum, there were over
30 discrete bands for Bg (Fig. 3 "Bg"). With papain digestion, the protein
bands were eliminated leaving the characteristic "step ladder" effect
commonly associated with lipopolysaccharide (LPS) (Fig. 3 "Bg pap").
When the AaY4 antigen preparation was analyzed using 0.5 ml of patient
serum in the incubation mixture (Fig. 3 "Aa"), about 50 discrete bands were
present. In addition to these bands there was also a diffuse band or "smear"
observed in the upper portion of the lane. Although the location of the
protein bands were highly reproducible from gel to gel, this diffuse smear
was not. Generally the smear occupied the upper half of the gel beginning at
the origin; but sometimes this smear did not begin until the level of the 200kd
molecular weight marker. If the AaY4 antigen was boiled for 45 minutes
before western blot analysis, many of the discrete protein bands disappeared
but the smear persisted (Fig. 3 "Aa boil"). With papain pretreatment of
antigen, all but two low molecular weight bands disappeared leaving only the
smear in the upper portion of the lane (Fig. 3 lane "Aa pap"). The presence
of the smear on western blots before or after boiling and papain digestion
suggests that persistence of the antigen after treatment is occurring rather
than aggregation or unveiling of antigen.

17

FIG. 2. Compilation of RIA data for all patients having a high antibody titer
to AaY4 showing the affect of boiling and papain digestion on antibody titers.
Panel a is the tetanus toxoid positive control (4 subjects) and panel b is the data
for AaY4 (32 subjects). The error bars indicate the standard error of the
mean.
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FIG. 3. A western blot using a low dilution (1/2) of patient serum showing
the effect of boiling and papain digestion on AaY4. Bg is run as a control for
papain digestion.
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To determine which bands represent the immunodominant antigen for
AaY 4, western blots were run and replicate lanes were stained with
progressively less serum from 1/250 ml

to 1/1024K ml (fig-4). With

increasing dilution, all of the protein bands were eliminated leaving the
smear in the upper portion of the lane when only 1/256K ml of serum was
used. In the original western blot, a faint smear was visible even at 1/1024K.
To determine the immunodominant antigens for the group of high responder
patients, 1/I00K ml of serum from 31 subjects was incubated with a single
lane. The results of this assay are summarized in Table 1. Note that sera
from all 31 of these high responding patients react with the smear in the
upper portion of the lane. Other bands are present for many of the patients at
1/100K; however, the discrete bands with the highest prevalence ( l OOKd,
98Kd, 85Kd) were found in only 34% of the subjects. In every patient (5
subjects) where the serum was serially diluted beyond 1/I00K ml, only the
smear was detected.
The properties of the "smear" antigen are consistent with a carbohydrate
(i.e. the antigen was heat and papain stable and did not focus into a discrete
band on western blots). To test this more directly, AaY4 sonicate was
subjected to a carbohydrate purification procedure involving extraction with
phenoVwater followed by precipitation with cold ethanol. This preparation
was run on a western blot and stained with 0.5 ml of patient serum. The
appearance was much like that observed with papain digestion of AaY4 (Fig.
5). Interestingly, the two papain resistant low molecular weight bands
copurified with the carbohydrate; however, these bands stained with
Coomassie blue and appeared to be protein.

22

FIG. 4. A typical western blot of AaY4 illustrating the immunodominant
antigens. Replicate lanes of AaY4 were run on polyacrylamide gel and
transferred to nitrocellulose. Decreasing amounts of a patient's serum (1/250
ml-1/1024K ml) were used in the incubation mixture for each lane to allow
visualization of the immunodominant antigen with subsequent staining. Note
that the discrete bands disappeared with decreasing amount of serum, but the
"smear" was still visible in the upper portion of the western blot with a serum
dilution utilizing 1/256K ml of serum. In the original western blot, the
smear was also visible at 1/1024K.
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FIG. 5 . Comparison o f papain digested AaY4 antigen with AaY4
carbohydrate on a western blot. Patients' sera are used at a low dilution (1/2
or O.5rnl) to reveal any antigens in the purified material.
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TABLE 1 . Prevalen c e of i n di vi du al bands on wes tern blot
for Actinobacillus actinomycetemcomitans s tr ai n Y4 i n hi gh
responder pati ents
Nu mber
3 1
10
10
10
9
9
8
7
6
5
3
3
3
2
2
1
1
1
1

of

i ndi vi du als

res p o ndin g

(%)b

B an da

1 00%
340/0
34%
34%
28%
28%
25%
21%
1 8%
1 5%
9%
9%
9%
6%
6%
3%
3%
3%
3%

s me ar
1 00 Kd
9 8 Kd
8 5Kd
9 9Kd
80Kd
6 8Kd
7 5Kd
87Kd
20 5Kd
1 8 0Kd
1 60 Kd
6 0Kd
58Kd
1 8Kd
1 5Kd
2 5Kd
2 1 0Kd
90Kd

a- B ands appearing on wes tern blot when s tained wi th 1/1 00,000 of
a ml of s erum in 4 ml of diluent
b-

1

subject

of

the

32

was

u navai lable

for

wes tern

blot
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The appearance of the Aa immunodominant antigen on western blots
prompted us to determine if this antigen was the serotype b specific antigen
which is thought to be a capsular polysaccharide (30). In double
immunodiffusion analysis, the extracted carbohydrate preparation showed a
line of identity with patient serum and rabbit serotype b specific antiserum
(Fig. 6 panel A). No reaction was seen with serotype a or c specific antisera.
In

addition, western blots using the rabbit serotype b specific antiserum

revealed a smear typical of that seen when using human serum (data not
shown).
Crossed immunoelectrophoresis was attempted to help establish whether
the smear on western blot actually represented a single antigen. After several
trials, it appeared the immunodominant antigen was not migrating at the
required pH. The carbohydrate extract as well as whole AaY4 sonicate was
analyzed using immunoelectrophoresis. The antigen forming the precipitin
bands

did

not

migrate

at

pH

8.6

explaining

why

crossed

immunoelectrophoresis was unsuccessful (Fig-6 panel B).
It was considered likely that the carbohydrate extract contained
lipopolysaccharide which might contribute to the smear observed on western
blots. Actinobacillus actinomycetemcomitans lipopolysaccharide (AaLPS)
was therefore analyzed on western blots and SDS-page gels (Coomassie and
silver stained) (28). The AaLPS preparation contained a diffuse band in the
upper portion of the lane which appeared very similar in silver stained gels
or western blots to the carbohydrate preparation (data not shown).
Coomassie staining revealed several protein bands in the AaLPS.
To better assess the contribution of LPS to the diffuse band in western
blots, the carbohydrate was further enriched. Two phenol/water extractions

28

FIG. 6. Double immunodiffusion and immunoelectrophoresis showing that
serotype-b specific rabbit antiserum and high responder patients recognize
the same irnmunodominant antigen.
Panel A: A double immunodiffusion analysis (Ouchterlony technique)
showing that rabbit serotype b specific antiserum and patient serum
recognize the same antigen. Peripheral wells P, B, A, C contained: patient
serum P, and Aa serotype B, A, C, serotype specific antisera respectively
(SuI each of a 1:2 dilution). The center well (E) contained AaY4
carbohydrate extract (40ul)
Panel B: Immunoelectrophoresis of the immunodominant antigen at pH
8.6. Well E contained l Oul of AaY4 carbohydrate extract and well S
contained l Oul of AaY4 sonicate. Two precipitin bands were noted when
using the whole sonicate, and a single band with the carbohydrate extract.
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A

B

30
and cold ethanol precipitations were carried out on the AaY4 sonicate.
Further purification was accomplished using a concentrator with a 30kd
molecular weight exclusion to remove low molecular weight material.
Finally this preparation was passed over a lipid A binding column to remove
LPS. Analysis of this preparation on SDS-page gels is presented in Fig. 7
(Fig- 7 "Aacarb coomassie" "Aacarb silver").

This demonstrates the

extracted antigen preparation before passage over the column. Note that the
low molecular weight protein bands seen in Fig. 5 are not evident in the
Coomassie stained gel. Discrete bands are also absent from the silver stained
gel; however, the smear or diffuse band is present in the upper portion of the
lane (Fig-7). The smear appears dark only at the top of the gel in this
photograph; but the typical smear pattern was apparent up to the middle
portion of the gel in the original. The carbohydrate extract was then passed
over a lipid A binding affinity column to remove LPS and analyzed on SDS
page gels. Actinobacillus actinomycetemcomitans

lipopolysaccharide,

which was papain treated, was used as a control. Silver staining of the AaLPS
SDS-gels before and after passage over the column indicated that the column
bound AaLPS effectively (Fig. 7 "AaLPSpap" "AaLPSpap column").
However, western blotting of the carbohydrate extract passed over the
affinity column still revealed a smear in the upper portion of the lane
suggesting that this antigen was not LPS (Fig. 7 "Aacarb column").
2. hnmunodominant Antigens of Actinobacillus actinomycetemcomitans
Serotype b in Early Onset Periodontitis Patients
In this s et of experi ments , the domi nant anti gens

of early ons et

peri odonti tis patients wi th a range of antibody ti ters for Aa s erotype
b (i ncludi ng both black and whi te subjects ) were exami ned.
objecti ve of thes e experi ments

was

The

to determi ne if the s erotype

3 1

FIG. 7. Persistence of the irnmunodominant antigen in the carbohydrate
preparation after removing protein and LPS. The carbohydrate preparation
was enriched by two cycles of phenol/water followed by cold ethanol
precipitation. Low molecular weight materials were removed by using a
concentrator with a 30Kd filter. LPS was used as a control to establish that
the lipid A binding column would remove AaLPS. SDS-page gels were
stained with Coomassie blue, silver or analyzed on western blot. Aacarb
coomassie: SDS-page gel of AaY4 carbohydrate extract stained with
coomassie blue, Aacarb silver: SDS-page gel of AaY4 Carbohydrate extract
stained with silver, AaLPSpap: SDS-page gel of AaY4 LPS that was digested
with papain stained with silver, AaLPSpap column: SDS-page gel of AaY4
LPS that has been digested with papain and passed over LPS binding affinity
column stained with silver, Aacarb Column: western blot (using a 1/50
dilution of patient serum) of AaY4 carbohydrate extract that has been passed
over an LPS binding affinity column. Although not apparent in the
photograph, a single discrete band was detectable in the original western blot
at 15kd. It appears that enough protein persisted, after all the purification
steps, to be detected by the very sensitive western blot.
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s peci fi c

carbohydrate

anti gen

that was immunodominant i n

hi gh

respondi ng subjects (mos t were black) was als o i mmunodomi nant i n
both

black

and

w hi t e

a n ti b o d y

p osi ti v e

su bj e c ts .

Radioi mmunoass ays were completed on 99 early ons et peri odonti tis
pati ents

(the early ons et peri odonti tis subset of the 48 1 subject

group)

to find subjects wi th a range of antibody titers reacti ve wi th

AaY 4.

Eleven white patients wi th a positive anti body titer, i ncluding

very low titers , were s elected.

Black s ubjects with simi lar anti body

ti ters to AaY4 were selected to compare with the white pati ents .
The speci fi ci ty o f the antibody respons es o f the 2 9 s elected
pati ents was then determi ned.

Double i mmunodi ffusion experiments

were run to help ass ess the specifici ty of the antibody res pons es to
AaY4.

Serum from 1 8 of the 29 subjects produced a li ne of i dentity

wi th an AaY 4 s erotype specifi c speci fic s erum indicating that thei r
respons es were s peci fi c (Fi g. 8 ) .
subjects '

anti bodi es

was

The s peci fi ci ty o f the remaini ng

determi ned usi ng

the competi ti on

ass ay.

Examples of the ass ay i llus trati ng speci fi c and nonspeci fi c reactiviti es
is s hown in Fi gure 9.

Heavily loaded wes tern blots of whole AaY4

s oni cate were us ed to allow all anti gens to be repres ented in ample
quantity.

For each patient, four replicate lanes were s tained us ing a

pati ent's s eru m
s erotype

-a,

that

was

-b(AaY4),

or

ei ther untreated
-c

anti gen.

or
In

prei ncubated
this

example,

wi th
only

preabs orpti on of the s peci fi c res ponder's s erum (subject A) wi th
s erotype-b anti gen (lane bib) completely eli mi nated the reacti vi ty
pres ent

in

the

c ontrol

non -preabs orbed

lane

( l ane

b/-).

Pre abs orpti on wi th ei ther of the other two s erotypes eli mi nated only
cross reactive anti gens wi th mos t of the reacti vi ty remai ning in the
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FIG. 8. Identity of the immunodominant antigen with the serotype specific
antigen. Double-immunodiffusion analysis (ouchterlony technique) showing
that serum from a high reponding patient previously shown to recognize the
same antigen as the rabbit serotype-b specific antiserum and patient serum
(from responders with a range of antibody responses) recognize the same
antigen in serotype-b sonicate that has been treated with protease K.
Peripheral wells P and PHS contained patient serum (from the subjects with a
range of antibody titers) and High responder serum(20ul of undiluted serum
for each). The center well S contained SuI of serotype-b sonicate (originally
having a protein concentration of 7ug/ml) that was treated with protease K.
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FIG. 9. Serological specificity of responses to Aa serotype b as detennined
by the competition assay using the western blot technique. Patient A: a
specific responder to serotype-b, Patient B: a patient that responded
nonspecifically to serotype-b, b/a: blot of serotype-b stained with serum
preincubated with serotype-a antigen, bib: blot of serotype-b stained with
serum preincubated with serotype-b antigen, b/c: blot of serotype-b stained
with serum preincubated with serotype-c antigen, b/-: blot of serotype-b
stained with untreated serum.

37

subject

A

mw

b/a

206K

1 00K
68K
42K

25K
1 8K
1 5K

B

bIb
1

b/c

b/a

b/a

bIb

b/c

b/.�

38
seru m (lanes bla, b/c).
responding

This result indicated that this patient was

specifically.

In

subject B,

a non-specific responder ,

preabsorption of the serum with any of the three serotype antigens
(lanes bla, bIb, b/c) eliminated all of the reactivity in the control
lane (lane b/-).

When this analysis was applied to the 1 1 subjects

lacking precipitin lines in the dou ble immunodiffu sion experiment
only 2 out of 1 1 were found to be responding specifically.

Further

examination of the data, showed that patients with an antibody titer
of 43 ,000 units

or

serotype-b,

the

while

common antigens
the

greater

demonstrated

lower responses

specific

tended

responses

to be

against

to
Aa

This analysis allowed selection of 20 subjects from

original group having a specific response to AaY4.

These

included 6 white and 14 black subjects.
To determine which antigen in the bacter ial sonicate was
responsible for the

antibody titer for each

of the 20

patients ,

replicate western blot lanes were stained with increasing dilu tions of
patient

seru m

in

a

limiting

dilution

analysis.

This

allowed

visualization of the immunodominant antigen at the end point.

This

assay was analogous to the radioimmunoassay (RIA) that was u sed to
determine the antibody titer.

Each western blot lane corresponds to

a well of a microtiter plate u sed in the RIA .
analysis is shown in Figure 1 0.

An example of this

As replicate lanes were stained with

progressively less serum (from 1 0 -4 to 1 0-6 ml) most of the antigen
bands

disappeared

leaving

only

the

immu nodominant

apparent at the highest dilution of serum (i.e. endpoint).

antigen

In this case

the immunodominant antigen at the endpoint was a smeared antigen
in the upper range of the lane.

The results of this analysis for all
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FIG. 10. The immunodominant antigen of Aa serotype b. A typical western
blot of Aa serotype-b illustrating the immunodominant antigen for a
particular patient. Replicate lanes of Aa serotype-b were run on
polyacrylamide gel and transferred to nitrocellulose. Decreasing amounts of
a patient's serum (1/250 ml-l/1024K ml) were used in the incubation mixture
for each lane. Note that the descrete bands have disappeared with the
decreasing amount of serum but the smear was still visible in the upper
portion of the lane at 1/100K ml of serum. In the original blot it was also
visible at l/lOOOK.
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the subjects is summarized in Table 2.
( 1 9/2 0-total,

The data indicated that 95%

1 3/ 14 black, 6/6 white) of the specific seropositive

subjects had a smeared antigen as the immunodominant antigen.
One subject reacted with only a 72kd antigen and another reacted
with

both a

antigens.
double

1 5kd

and the

smeared

antigen as immunodominant

All but these two patients gave a reaction of identity in
immunodiffusion

antiserum.

experiments

using

serotype

spec ific

The smear on western blot of the patient detecting the

1 5Kd antigen had the same appearance as that observed for all the
other patients.

I believe this is also a response to the serotype

specific antigen; the antibody titer was too low for a visible reaction
in double immunodiffusion analysis.

3.

Irrununodominant Antigens of Actinobacillus actinomycetemcomitans

Serotypes-a and-c in High Responder Patients
Nineteen subjects with the highest anti-Aa serotype-a antibody titers and
twenty one with the highest serotype-c antibody titers were selected from a
group of 150 clinically characterized subjects. This was about 15% of the
total group in each case. For serotype-a 11 were black and 8 white. For
serotype-c 15 were black and 6 white. All but 4 of these subjects had early
onset forms of periodontitis with 12JP, 6SP, and INP for serotype-a and
11JP, 8SP, and 2NP for serotype-c.
To determine which of these high responding patients were responding
specifically to their respective Aa antigens, competition analysis was
performed using all 3 Aa serotypes. The specificity of an individual patient's
response is illustrated in Figure 11. Heavily loaded western blots of whole
cell sonicate were used to allow all immunodominant antigens to be
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TABLE 2. The immunodominant antigens of serologically specific
early onset periodontitis patients for Actinobacillus
a ctinomycetemcomitans serotype-b (AaY4)

Subject

1
2
3
4
5
6
7
8
9
10
1 1
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Race

Titer(RIAunits)

W
W
W
B
B
B
B
W
B
B
W
B
W
B
B
B
B
W
W
B
B
B
B
B
B
W
W
B
W

940
955
1 ,4 0 0
1 ,4 0 0
1 ,8 0 0
3 ,500
6,000
1 0 , 5 00
1 3 ,500
1 8 ,7 0 0
3 2,000
42,600
64 , 0 0 0
64 , 0 0 0
1 2 2 , 3 00
1 28 , 000
149,500
1 9 2 , 000
1 9 6 , 3 00
1 98 ,4 0 0
2 3 0 ,4 0 0
2 3 0 ,400
24 3 , 200
2 54 ,7 00
254 ,7 0 0
402,900
5 0 6 ,8 0 0
7 3 2 , 200
7 9 3 , 6 00

Specific
Response

+

+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

D ominant
antigen(s) a
nd
nd
nd
nd
nd
nd
SMEAR, 1 5Kd
nd
nd
72Kd
nd
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR
SMEAR

a- B ands appearing on western blot when stained with
decreasing amounts of serum ( 1 /250 ml- 1 / 1 024,000ml)
in4 ml of diluent
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FIG. 1 1 . Competition assay using the western blot technique to detennine the
specificity of an individual patient's antibody response. Notice that
preincubation of serum with antigen from any of the three serotypes
removed antibody molecules reactive with that antigen on the blot (lanes a/a,
bib, c/c). In contrast, in the control when there was no preabsorbtion of sera,
there was reactivity in each lane (lanes a/-, b/-, c/-). When antigen
preparations from the remaining two serotypes were used to preabsorb the
sera, the results indicated a specific response for serotypes -b and -c but not
for -a. For serotypes -b and -c preincubation with either of the remaining
serotype antigens resulted in elimination of reactivity for Aa common
antigens but allowed staining of serotype specific antigens (lanes b/a, b/c, c/a,
clb). For serotype-a, preincubation of sera with antigen of any of the three
serotypes completely eliminated reactivity with antigens present on the
western blot (lanes a/a, alb, a/c). These results indicated that this patient
responded specifically to serotypes -b and -c but not to serotype-a. a/a: blot
of serotype-a stained with serum preincubated with serotype-a antigen, alb:
blot of serotype-a stained with serum preincubated with serotype-b antigen,
a/c: blot of serotype-a stained with serum preincubated with serotype-c
antigen, a/-: blot of serotype-a stained with untreated serum, b/a: blot of
serotype-b stained with serum preincubated with serotype-a antigen, bib:
blot of serotype-b stained with serum preincubated with serotype-b antigen,
b/c: blot of serotype-b stained with serum preincubated with serotype-c
antigen, b/-: blot of serotype-b stained with untreated serum, c/a: blot of
serotype-c stained with serum preincubated with serotype-a antigen, clb:
blot of serotype-c stained with serum preincubated with serotype-b antigen,
c/c: blot of serotype-c stained with serum pre incubated with serotype-c
antigen, c/-: blot of serotype-c stained with untreated serum.
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represented in ample quantity. Four replicate nitrocellulose lanes (a set of
four for each serotype) were stained using patient serum that was either
untreated or preincubated with serotype-a,-b, or-c antigen. For serotype-a,
preincubation with antigen of any one of the three serotypes removed
antibody molecules reactive with serotype-a antigen present on the blot (lanes
a/a, alb, alc).

Lane a/- was a control with no preabsorbtion of serum. The

data indicated that this patient did not respond to serotype-a specifically
because antigens from serotypes-b or-c could inhibit staining of a blot of
serotype-a. Therefore, I concluded the response to serotype-a was only to
cross-reactive antigens common between the three serotypes. For serotypes
b and-c, preincubation with serotype-b or-c antigen respectively (lanes bib
and c/c) removed all reactivity from the patient's serum.

However,

preabsorbtion with either of the other two remaining serotypes antigen (lanes
bfa, b/c, cIa, c/b) eliminated only a small portion of the reactivity present in
the patient's serum. Lanes b/- and c/- are controls with no preabsorbtion of
serum. This indicated that the serum of this patient contained reactivity for
serotype specific antigens of serotypes-b and-c.

This patient therefore

responded specifically to serotypes-b and-c but not specifically to serotype-a.
This same analysis was used for all of the serotype-a and-c high responders to
determine the specificity of each individual's response. Only about half of
high responders were responding specifically to their respective antigen (9 of
19 for a and 12 of 21 for c).

It was common to find individuals that

responded specifically to only one serotype. In

some cases, however,

individuals responded specifically to more than one serotype as was shown in
Fig. 1 1 . For serotype-a, 5 were black and 4 were white. For serotype-c 9
were black and 3 were white. All but 2 of these subjects had early onset
disease with 6JP, 3SP, ONP for serotype-a and 5JP, 5SP, 2NP for serotype-c.
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Those individuals that did not respond specifically to the appropriate antigen
(a or c) often specifically responded to serotype-b.

Only the patients

responding specifically to the appropriate Aa serotype were used in the
studies to determine the dominant antigens.
To establish the irnrnunodominant antigens for serotypes-a and-c, I
used limiting dilution analysis on western blots. Replicate lanes were stained
with progressively less serum (from 1/250 to 1/1024,000 of a rnI). With
increasing dilution, most of the antigen bands disappeared leaving only the
irnrnunodorninant antigen(s) apparent at the highest dilution of serum (i.e.
endpoint). An example of this analysis is shown in Fig. 12. At a low serum
dilution many discrete bands were present and a diffuse or smeared high
molecular weight antigen was also present (lane 1/250). When the serum was
further diluted to 1/1 000 { 1/1000th ( 1 0-3 ) of a rnl of serum } , many of the
discrete bands disappeared. Therefore, the antibody titer reactive with these
antigens was low. In this case, the smeared diffuse antigen was not the
immunodominant antigen as the titer for this antigen was low. It was also of
interest to note that some of the antigens that displayed intense staining at the
lowest dilution (ex. the band at approximately 50Kd) disappeared at a serum
dilution of 1/1000. The intensity of staining of individual bands at a low
dilution of serum did not always correlate with the observed antibody titer
for a given antigen when the antibody was diluted out further. For this
patient, a serum content of 1/64K (1/64,OOOth of a ml of serum) resulted in a
dominant antigen that was a discrete band having a molecular weight of 90kd.
Although not apparent in the photograph, the 90Kd antigen was visible at a
serum dilution of 1/256K (1/256,000th of a ml of serum). Similar analysis
was completed for all the high responder patients. For some patients a single
antigen was stained at the endpoint.

For most two or three antigens
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FIG. 1 2. A typical western blot of Aa serotype-a illustrating the
imrnunodominant antigen for a particular patient. Replicate lanes of Aa
serotype-a were run on polyacrylamide gel and transferred to nitrocellulose.
Decreasing amounts of a patient's serum (1/250 ml-1/1024K ml) were used
in the incubation mixture for each lane. Note that antigens that have elicited
low titer antibodies are apparent only at low dilutions of serum while the
90Kd imrnunodominant antigen is still visible at a serum dilution of 1/64K
( 1 /64,000 of a ml of serum).
In the original western blot, the
imrnunodominant antigen was also visible at 1/256K).
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remained at the endpoint with no individual having more than four. The data
indicated that for serotype-a there were several different immunodominant
antigens for different patients but none was present in more than 44.4% of
the

serotype-a high

responders

(table3 ) .

For

serotype-c

the

immunodominant antigens included a number of discrete bands and a diffuse
band typical of LPS or capsular polysaccharide (table4). Only two of these
antigens were present in the majority of serotype-c high responders: 92%
( 1 1/12) had the diffuse or smeared antigen and 67% (8/ 1 2) had an
approximately l 5Kd antigen.
To determine if the l 5Kd band was a protein antigen, two replicate lanes
of a western blot of Aa serotype-c were stained using serum from a patient
known to be responsive to this antigen. One of the lanes was left untreated
while the other was exposed to protease K digestion. As shown in figure 1 3,
protease K digestion eliminated the discrete low molecular weight bands in
the 1 5Kd region of the blot. The enzyme did not appear to affect the smeared
antigen. This result indicated that the 1 5Kd immunodominant band was a
protein antigen. Competition assays revealed that the 1 5Kd antigen was a
common antigen between the three serotypes while the smeared antigen was
serotype specific. In Fig. 14, competition assays for serotype-c are shown
for two patients: one that responded specifically to Aa serotype-c and one
that did not. For the specific responder untreated serum stained both the
smeared antigen as well as the 1 5Kd antigen (lane c/- patient A). The 1 5Kd
antigen was eliminated from the blot by incubating the serum with antigen
from any of the three serotypes (lanes cia, c/b, clc patient A). This indicated
that this antigen was not serotype specific. In contrast, the smeared antigen
was only eliminated when serum was incubated with serotype-c antigen (lane
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TABLE 3. Prevalence of individual bands on western blot
for Actinobacillus actinomycetemcomitans serotype-a
Number of individuals responding (%)b
4
2
2
2
1
1
1
1

44.4%
22.2%
22.2%
22.2%
1 1.1%
1 1. 1%
1 1. 1%
1 1.1%

smear
8 3 Kd
1 5Kd
14Kd
1 03 Kd
90Kd
57Kd
2 8Kd

a- B ands appearing on western blot when stained with decreasing
amounts of serum ( 1 /250 ml- 1/1 D24,000ml)in 4 ml of diluent
b- 6 patients responded to a single antigen at endpoint, 3 responded
to three antigens at endpoint

5 1

TABLE 4. Prevalence of individual bands on western blot
for Actinobacillus actinomycetemcomitans serotype-c
Number of individuals responding (%) b
1 1
8
4
3
2
2
2

9 1 .6 %
66.6%
33.3%
25.0%
1 6.6%
1 6.6%
1 6.6%

Banda
smear
1 5Kd
1 4Kd
57Kd
170Kd
1 60Kd
78Kd

a- B ands appearing on western blot when stained with
decreasing amounts of serum ( 1 /250 ml- 1 / 1 024,OOOml)
in 4 ml of diluent
b- 5 patients responded to two antigens at endpoint,5 patients
responded to three antigens at endpoint, 1 patient responded to four
antigens at endpoint.
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FIG. 1 3. A western blot using a low dilution (1/250 rnl) of patient serum
showing the effect of protease K digestion on the antigens of Aa serotype-c.
Note that the 15Kd band was eliminated from the western blot by the protease
while this treatment had no affect on the smeared antigen. Aa-c: western
blot of untreated antigen, Aa-c protease: western blot of Aa-c that was
digested with protease K before staining.
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FIG. 14. Competition assay using the western blot technique showing that the
1 5Kd antigen is an Aa common antigen and the smeared antigen is a serotype
specific antigen. Patient A: a specific responder to serotype-c, Patient B: a
patient that responded nonspecifically to serotype-c, cia: blot of serotype-c
stained with serum preincubated with serotype-a antigen, c/b: blot of
serotype-c stained with serum preincubated with serotype-b antigen, c/c:
blot of serotype-c stained with serum preincubated with serotype-c antigen,
c/-: blot of serotype-c stained with untreated serum.
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c/c patient A) and not with the other two antigens (lane cia, c,b patient A).
Serum from the patient with the nonspecific response lacked reactivity with
the smeared antigen but did recognize the 1 5Kd antigen (lane c/- patient B).
The 1 5Kd antigen was again eliminated with antigen from any of the three
serotypes (lanes cia, c/b, c/c patient B) confirming the lack of serotype
specificity.
The appearance of the smeared immunodominant antigen on western blot
and its resistance to protease was consistent with either LPS or a
carbohydrate antigen.

To further characterize the antigen, double

immunodiffusion analysis was performed. This analysis utilized serotype-c
specific rabbit antisera which has been shown to have reactivity with mannan
from serotype-c and no reactivity with LPS (3 1). Antigen from serotype-c
was treated with protease K to remove protein antigens and then added to the
center well. Serum from a patient known to be positive for the smeared
antigen was placed in one peripheral well and the serotype specific rabbit
antisera was placed in an adjacent peripheral well. This analysis resulted in a
line of identity indicating that the non-protein antigen recognized by the
rabbit antiserum was the same antigen as the immunodominant antigen
recognized by the patient's serum (Fig. 1 5). This result was found for 9 of 1 1
of the serotype-c specific high responders that had the smeared antigen as a
dominant antigen. The remaining 2 subjects showed a reaction of non
identity with the serotype specific antigen recognized by the rabbit
antiserum. The immunodominant antigen in man is apparently the mannan
described by Zambon (3 1). When antigen not subjected to proteolysis was
used other precipitin lines were observed that were eliminated by the enzyme
digestion indicating that the proteolytic digestion was effective.
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FIG. 1 5 . Double-immunodiffusion analysis (Ouchterlony technique)
showing that rabbit serotype-c specific antiserum and patient serum
recognize the same antigen in serotype-c sonicate that has been treated with
protease K. Peripheral wells P and C contained patient serum and rabbit
serotype-c specific antiserum respectively (20ul of undiluted serum for
each). The center well S contained SuI of serotype-c sonicate (originally
having a protein concentration of 7ug/ml) that was treated with protease K.
Note precipitin lines between P and C. These are absorbtion lines which
derive from the fact that the serotype specific rabbit antiserum was absorbed
with antigen preparations from the other two serotypes. Therefore, the
rabbit antiserum contains antigens form serotypes -a and -b. Several
different concentrations of antigen and sera were used and only one
precipitin line was found in any case.
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DISCUSSION

Analyses of the antibody reactive with AaY4 sonicate by RIA and
western blot analysis strongly suggest that the immunodorninant antigen for
AaY4 is a carbohydrate. The immunodominant antigen is the antigen that is
responsible for the observed antibody titer in the high responder subjects.
When sera are used at high dilution, only high titer antibody measurable.
The antigen detectable at the highest serum dilution on the western blot
corresponds to the antigen responsible for the endpoint or antibody titer in
the RIA. This antigen was heat stable, resistant to proteolytic digestion,
purified with carbohydrate, and appeared like carbohydrate on western blot
(i.e., carbohydrate does not focus into a discrete band on western blot). This
antigen preparation contains the serotype-b specific antigen as demonstrated
in double immunodiffusion analysis. It has been suggested that the type
specific antigen of AaY4 may represent capsular carbohydrate as it is a
surface antigen readily detectable on whole cells using immunofluorescence
(30). A lipid A binding affinity column which bound AaY4LPS failed to
retain the "smear antigen" found on western blots of AaY4 carbohydrate
extract. This further supports the idea that the immunodorninant antigen may
be a capsular polysaccharide.
The next set of experiments examined the immunodominant antigen in
AaY4 for antibody positive subjects that had a range of titers. This would
determine if an immunodominant response to the serotype specific
carbohydrate antigen was restricted to the high responding patients.
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range
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antigen

antibody

for

titers

antibody

would

be

positive

the

immunodominant antigen found in the high responding

same

subjects,

patients were selected to include subjects of both races with a range of
antibody

titers

to

AaY4.

The

results

immunodominant antigen of AaY 4 in
specific,

early

onset

periodontitis

showed

that

antibody positive,

patients

was

the

the

serotype

serotype-b

antigen as was previously found in earlier work limited to high
responding patients.

This was the case for the entire range of

antibody specific responses although most of the very low titers
were not AaY 4 specific.

The competition (inhibition) assay showed

that these low responding subjects generally had a specific response
to serotype-a or-c.

Thus, the assay probably measured low titer

antibody directed towards cross reactive antigens when Aa Y 4 was
used as the antigen for RIAs and western blots.
The relationship between antibody response to the "smeared"
antigen and race was also examined as initial work showed that most
high responders to the smeared antigen were black.
of experiments indicate that both black and white

The second set
subjects

with

specific antibody responses to AaY4 were responding to the serotype
specific antigen.

While this seems to suggest the absence of a race

affect on the antibody response, it should be understood that only
those white subjects that had a specific response to AaY 4 were
selected for the study.

Gunsolley et al

have shown that the majority

of white subjects were not seropositive for AaY4, while the v ast
majority of black subjects were seropositive (in press Gunsolley et ai,

7).

It was also noted that white subjects had lower antibody titers
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than black subjects.

Either white subjects do not respond to AaY 4 as

frequently or with as high an antibody titer as black subjects, or they
are not as frequently infected with Aa as blacks.
A similar race effect has been shown for the antibody response to
carbohydrate antigens of Haemophilus
attributed

to

an

immune

response

immunoglobulin light chain allotype (5).
that

major

histocompatibility

injluenzae,
gene

which has been

associated

with

Km l

It has also been suggested

c omplex

(specifically

HLA-DQ

molecules) may be responsible for the ability to respond to microbial
mannans found in Aa (32).
Examination of the data revealed that, with two exceptions, AaY4
specific sera had an antibody titer of 43 ,000 units of antibody or
greater.

I examined the dominant antigens of the non-specific group

and found that 4 out of 9 had a response to a smeared antigen. The
response to the

smeared antigen in these subjects was not serotype

specific indicating that having antibody reactive with a smear is not
sufficient to verify a response to the serotype specific antigen.
Based on · these data, it is suggested that any study of antibody
responses to antigens of Aa should include assays of specificity to try
to assure that the patients have been exposed to the antigen of
interest.

Subjects with moderate to low antibody responses would

include many individuals responding non-specifically to the serotype
of interest.

The result would be highly variable data with apparent

immunodominant responses to different cross reactive antigens.
Analysis of antibody reactive with A. actinomycetemcomitans serotype-a
by limiting dilution analysis of w estern blots indicated that the
immunodominant antigen for serotype-a was highly variable from patient to
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patient. In contrast, most patients with high antibody titers to serotype-c had
a 1 5Kd protein antigen and/or a diffuse band as their dominant antigens.
Results of double immunodiffusion assays indicated that the smeared antigen
is the serotype-c specific antigen. This antigen has been shown to be mannan
and not LPS and appears to be part of the bacterial capsule (3 1 ) .

I

particularly wanted to focus attention on dominant antigens that elicited a
response in a majority of the high responder patients as it is the response to
antigens that might provide information of prognostic value for the patient
and clinician. These dominant antigens might also make good candidates for
vaccines that could elicit protective antibody responses. For serotype-a, no
particular dominant antigen was detectable in the majority of patients.
Several dominant antigens were detected for serotype-c but only two were
found in the majority of the serotype-c high responders. The 15Kd antigen
was sensitive to protease K digestion and therefore appeared to be a protein.
This antigen also appeared to be common to all three serotypes and was often
present in western blots. This band could be eliminated in competition assays
where serum was incubated with any of the three Aa serotype sonicates. This
was not the case for the smeared serotype-c antigen. This antigen, which was
recognized by the majority of serotype-c high responders, gave a reaction of
identity with the serotype-c specific rabbit antisera in double
immunodiffusion assays, indicating that this antigen was serotype-c specific.
Furthermore, antigen could only be eliminated from western blots when
serum was incubated with serotype-c sonicate but not-a or-b.
When these results are compared with previous data from serotype-b it
is apparent that the dominant antigen for serotype-b is similar to the
serotype-c smeared antigen. Ouchterlony tests indicate that these antigens
are the serotype specific carbohydrate and may represent capsular

63
polysaccharides. LPS has not been ruled out as the dominant antigen for
serotype-b. However, analysis of sugar residues from the serotype specific
carbohydrate by Zambon et al suggest that this antigen is not LPS (32). For
the 2 subjects (2 of 12 serotype-c specific high responders) having a reaction
of non-identity with the serotype-c specific rabbit antiserum, LPS remains a
possibility.
The serotype specific carbohydrate, which is known to be associated with
the cell surface of Aa and may represent capsule, could be a virulence factor
for Aa as it is for several other organisms.

Purified serotype specific

carbohydrate from Aa serotype-c is the serotype specific antigen and has
been identified as mannan (30,3 1). Capsular polysaccharide is known to
inhibit phagocytosis of many bacteria (e.g., S. pneumoniae). In part, this
appears to be the result of inhibition of the alternative complement pathway
and decreased opsonization (10,12).

Mannans isolated from S. cerevisiae

have been shown to inhibit the respiratory burst and release of
myeloperoxidase in phagocytes (29).

Therefore, the serotype specific

carbohydrate may be a virulence factor for Aa.
Pneumococcal capsular polysaccharide has been shown to persist for long
periods in mice; such polysaccharides have a half-life of up to 50 days (22).
If the AaY4 carbohydrate is as resistant to degradation in vivo (by e.g.,
bacterial and PMN proteases) as it is in vitro, it could also persist for long
periods of time within the periodontal tissues. Bacteria ( 14,21) and antigens
of AaY4 (3,4) are observable within the periodontal tissues of juvenile
periodontitis subjects. If the carbohydrate of AaY4 persists in the tissues, it
might stimulate repeated cycles of antibody synthesis.

Thus, long term

persistence might explain the high titer of antibody reactive with this antigen
in periodontitis patients.
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If the

immunodominant antigen is in fact a carbohydrate, the very issue of

its potential immunogenicity is quite interesting. For example, a T dependant
(IgG) response is not typically seen with a carbohydrate antigens. The T cell
help could be obtained through presentation of the carbohydrate in the
context of la. This has yet to be demonstrated for a carbohydrate antigen.
Alternatively, either of the two proteins that copurify with the carbohydrate
may be attached to the carbohydrate allowing Ia binding. Another possibility
would be the availability of T cell help through polyclonal T cell activation in
the periodontal tissues or lymph node. Future studies are planned to examine
the behavior of the AaY4 carbohydrate antigen in different antigen
presentation systems to determine the mechanism of production of the IgG
response.
High antibody titers to AaY4 have been associated with localization
and decreased severity of disease in juvenile periodontitis (6,20). Future
studies will examine the relationship of antibody response to the
immunodominant antigen as a function of disease severity and extent to see if
antibody directed against this antigen is protective.

Levels of antibody

directed against the immunodominant antigen may also correlate with disease
severity. If this is the case, measuring antibody to the immunodominant
serotype specific carbohydrate antigen may decrease false positive results in
antibody data due to cross-reactive antigens shared by the three serotypes.
The immunodominant carbohydrate antigens for serotypes-b and-c appear
to be potent antigens, at least for black subjects. The enormous antibody
response (very high titer) observed for serotype-c and especially serotype-b
may be due in part to the presence of highly immunogenic epitopes on these
antigens or it may be due to long term persistence of these antigens in the
periodontal tissues. Bacteria (14,21 ) and antigens (3,4) of Aa are observable
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in the periodontal tissues.

The serotype-c and-b specific carbohydrate

antigens have been shown to be stable to protease and the serotype-b specific
antigen will withstand boiling for 45 minutes.

Therefore, both potent

immunogenicity as well as stability may explain the extremely high antibody
titers that have been observed.
I found that the immunodominant antigen was often not the most intensely
staining antigen at low serum dilution.

Some bands that stained quite

intensely at low serum dilution did not titer out very far as blots were stained
with increasing dilutions of serum. Therefore, I feel, it is important to dilute
the serum with limiting dilution analysis as was done here. Staining intensity
alone is not adequate to establish the immunodominance of particular
antigens on western blots.
I my conclusion, the immunodominant antigen for Aa serotype-a is
highly variable from patient to patient. Most patients with high antibody
titers to serotype-c responded to a 1 5Kd protein antigen and/or a smeared
antigen. The immunodominant antigen for AaY4 in both high responders
and specific responders over a range of antibody titers was also a smeared
antigen. This smeared antigen recognized by the patient's serum was also
recognized by serotype specific rabbit antiserum. These data support the
conclusion that the smeared immunodominant antigen was the serotype
specific carbohydrate which appears to be part of the Aa capsule (30,3 1 ,32).
The carbohydrate antigens therefore appear to be highly immunogenic and
may be important antigens for Aa serotypes-b and-c.

This potent

immunogenicity may explain the enormous antibody titers that are found
even when AaY4 is found in low numbers. The immune response to these
antigens may relate to the severity and extent of disease. Future work will
examine the relationship of these responses to clinical status.
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